NEOGAP Therapeutics is a clinical-stage biopharmaceutical startup focused on immuno oncology. Their pharmaceutical product, personalized tumor trained lymphocytes, offers even one customized cell treatment that is meant to precisely target and destroy cancer in a tailored environment, with very minor side effects.

Pharmaceutical

Health Care

Biotechnology

NEOGAP Therapeutics AB

Samuel Svensson

Hanjing Xie

Ola Nilsson

Hans Grönlund

Claudia Carvalho Queiroz

Andreas Kaiser

Anne-Laure Joly

Andrea Salmén

Research and Development

Leadership Team

Teams at NEOGAP Therapeutics AB

Research and Development

Leadership Team